Clinical Trial

A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The main objective of this study is to assess the safety and tolerability of ABBV-932 in healthy adult male participants.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-30
Trial Details
NCT Number NCT06953934
Lead Sponsor AbbVie
Conditions Healthy Volunteer
Enrollment 8 participants
Start Date 2026-05-04
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-29